Anavex Life Sciences Corp. (AVXL)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 6.84 |
| Open | 7.00 |
| Bid | 6.73 x 300 |
| Ask | 6.76 x 400 |
| Day's range | 6.72 - 7.24 |
| 52-week range | 3.25 - 10.45 |
| Volume | |
| Avg. volume | 1,144,593 |
| Market cap | 570.484M |
| Beta (5Y monthly) | 0.63 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.50 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 33.67 |
ZacksMirum (MIRM) Gets EC Approval for Livmarli Label Expansion
The European Commission approves Mirum's (MIRM) Livmarli for the treatment of progressive familial intrahepatic cholestasis in patients three months of age and older.
ZacksHilleVax (HLVX) Tanks as Norovirus Vaccine Study in Infants Fails
HilleVax's (HLVX) phase IIb NEST-IN1 study evaluating HIL-214 for preventing acute gastroenteritis caused by norovirus infection in infants fails to meet its primary efficacy endpoint. Stock falls.
Simply Wall St.Institutions own 38% of Anavex Life Sciences Corp. (NASDAQ:AVXL) shares but individual investors control 59% of the company
Key Insights Significant control over Anavex Life Sciences by individual investors implies that the general public has...
© 2024 Yahoo. All rights reserved.